Back to BlackRock, Inc. BlackRock, Inc.

ARCTARCT
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in ARCTURUS THERAPEUTICS HLDGS

BlackRock, Inc. holds 2.6M shares of ARCT (ARCTURUS THERAPEUTICS HLDGS), worth $17.6M as of 2026-Q2. The position was increased (+0.0% shares). ARCT represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$17.6M

Current Shares

2.6M

Total Value Change

-$33.2M

Total Shares Change

-375,589

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.6M
+0.0%
$17.6M0.0%$6.72
28
2026-Q1
Decreased
2.6M
-0.2%
$20.2M0.0%$7.91
0
2025-Q4
Increased
2.6M
+2.1%
$16.1M0.0%$6.19
29
2025-Q3
Decreased
2.6M
-2.9%
$47.3M0.0%$18.78
0
2025-Q2
Decreased
2.6M
-4.3%
$34.4M0.0%$13.33
0
2025-Q1
Decreased
2.8M
-7.7%
$29.2M0.0%$11.58
0
2024-Q4
New
3M
-
$50.7M0.0%$16.58
41

Other major holders of ARCT: BNP PARIBAS FINANCIAL MARKETS, ARK Investment Management LLC, FEDERATED HERMES, INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used